Boston Scientific reports positive outcomes from the ADVANTAGE AF trial’s second phase, assessing the Farapulse and Farapoint ...

Roche reported flat Q1 sales for its diagnostic division, citing headwinds in China, but reaffirmed the market’s strategic ...

Medtronic has signed an agreement for the distribution of Dragonfly Endoscopy’s pancreaticobiliary system in the US.

The GHIT Fund has awarded a grant of ~$4.5m to Fluxus for developing an ultrasensitive point-of-care (POC) urine test for ...

Following in the footsteps of several pharma companies, life sciences giant Thermo Fisher is doubling down on investments at ...

Roche has introduced its Chest Pain Triage algorithm, which is designed to rapidly identify acute coronary syndrome (ACS).

CEO Gary Guthart quelled concerns of reflexive pricing, with production and manufacturing optimisation a priority instead.

Epiminder has received FDA authorisation through the De Novo classification for its implantable continuous EEG monitoring ...

Semiconductors are used in half of all medical devices, with impending tariffs on their import likely to impact the US ...

Novocure has obtained CE Mark approval for its Optune Lua device to treat adults with metastatic non-small cell lung cancer ...

Vivasure hope to find room in a competitive market with its surtureless implant that is absorbed 180 days after vessel ...

BD has received 510(k) clearance from the FDA for the Phasix ST Umbilical Hernia Patch, enabling the launch of the product ...